Initial (ng/mL) | Confirmatory (ng/mL) | ||
(1) | Buprenorphine Metabolite | 10 | 100 |
(2) | Butorphanol | .15 | 100 |
(3) | Clonazepam Metabolite | 300 | 100 |
(4) | Fentanyl Analogs | .5 pg/mL | .05 pg/mL |
(5) | Flunitrazepam Metabolite | 300 | 100 |
(6) | Flurazepam Metabolite | 300 | 100 |
(7) | Hydrocodone | 2000 | 2000 |
(8) | Hydromorphone | 2000 | 2000 |
(9) | Ketamine Metabolite | 100 | 200 |
(10) | Lorazepam | 300 | 100 |
(11) | Lysergic acid diethylamide (LSD) | 0.5 | 0.2 |
(12) | Meperidine &/or Metabolite | 100 | 100 |
(13) | Meprobamate | 100 | 200 |
(14) | Methadone | 300 | 300 |
(15) | Methylenedioxyamphetamine (MDA) | 500 | 250 |
(16) | Methylenedioxyethylamphetamine (MDMA/MDEA) | 500 | 250 |
(17) | Midazolam Metabolite | 300 | 100 |
(18) | Nordiazepam | 300 | 100 |
(19) | Oxycodone | 100 | 100 |
(20) | Oxymorphone | 100 | 100 |
(21) | Pentazocine | 100 | 100 |
(22) | Propoxyphene Metabolite | 300 | 300 |
(23) | Temazepam | 300 | 300 |
(24) | Tramadol | 100 | 100 |
(25) | Triazolam Metabolite | 100 | 100 |
(26) | Zolpidem | 100 | 100 |
(27) | Amphetamines and methamphetamines | 1000 | 50 |
(28) | Cocaine | 150 | 100 |
(29) | Marijuana/cannabinoids (THC) metabolites | 50 | 15 |
(30) | Opiates (narcotics) | 2000 | 2000 |
(31) | Phencyclidine (PCP) | 25 | 25 |
(32) | Barbiturates | 300 | 200 |
(33) | Benzodiazepines (Nordiazepam) | 300 | 100 |
(34) | Methaqualone | 300 | 300 |
(35) | Alcohol/Ethanol | 25 | 20 |
(36) | 6-Acetylmorphine | 10 | 10 |
(37) | Morphine and Codeine | 2000 | 2000 |
(38) | N-Benzylpiperazine | 1000 | 1000 |
(39) | 3-FMC and 4-FMC | 1000 | 1000 |
(40) | Methylone | 1000 | 1000 |
(41) | Methedrone | 1000 | 1000 |
(42) | Ethylone | 1000 | 1000 |
(43) | Butylone | 1000 | 1000 |
(44) | Ecstasy | 250 | 100 |
(45) | Pentedrone | 1000 | 1000 |
(46) | Methoxetamine | 1000 | 1000 |
(47) | alpha-PVO | 1000 | 1000 |
(48) | Synthetic Cathinones (Bath salts1) | 20 | 20 |
(49) | Kratom | 10 | 10 |
(50) | Propofol | 500 | 500 |
Synthetic Cannabinoids2 (K2, Spice) | 5 | ||
Urine K2 Metabolites confirmation cutoffs: | |||
(51) | 5-F-AB-PINACA | .5 | 5 |
(52) | 5-F-AKB48 | .5 | 2.5 |
(53) | 5-F-AKB22 | .5 | 5 |
(54) | AB-CHMINACA | .5 | 2.5 |
(55) | AB-FUBINACA | .5 | 2.5 |
(56) | AB-PINACA | .5 | 5 |
(57) | ADBICA | .5 | 5 |
(58) | ADB-PINACA | .5 | 5 |
(59) | AKB48 | .5 | .5 |
(60) | AM2201 | .5 | .2 |
(61) | AM694 | .5 | .5 |
(62) | BB-22 | .5 | 5 |
(63) | JWH018 | .5 | .2 |
(64) | JWH019 | .5 | .2 |
(65) | JWH073 | .5 | .2 |
(66) | JWH081 | .5 | .5 |
(67) | JWH122 | .5 | .2 |
(68) | JWH200 | .5 | .5 |
(69) | JWH203 | .5 | .5 |
(70) | JWH210 | .5 | .5 |
(71) | JWH250 | .5 | .5 |
(72) | JWH398 | .5 | .5 |
(73) | MAM2201 | .5 | .2 |
(74) | PB-22 | .5 | 5 |
(75) | RCS-4 | .5 | .53 |
(76) | RCS-8 | .5 | .5 |
(77) | UR-144 | .5 | .5 |
(78) | XLR11 | .5 | .2 |
(79) | AM2001 | .5 | .5 |
1 Includes MDPV, Naphyrone, Dimethylcathione, Ethcathionone, Pyrovalerone.
2 Common synthetic cannabinoid compounds tested include: AM 2201 Hydroxyphentyl, JWH 018 Pentanoic Acid, JWH 073 Butanoic Acid, 5-Fluro ADB Metabolite 7, AB-Fubinaca Metabolite 3, BB-22 3-carboxyindole, JWH-122 Hydroxypentyl, AB-Fubinaca Metabolie 4, PB-22 3-carboxyindole, MDMB-Fubinaca Metabolite M1, UR-144 Hydroxypentyl, UR-144 Pentanoic acid, XLR11 Hydroxypentyl.
Cal. Code Regs. Tit. 15, § 8207
Note: Authority cited: Sections 2801, 2808 and 2809, Penal Code; Sections 11349(e) and 19572, Government Code; and Section 599.963, California Code of Regulations. Reference: Sections 2801 and 2809, Penal Code; Executive Order D-58-86 (dated September 24, 1986); Code of Federal Regulations, Title 49, Part 40, Subpart F, Section 40.89, Section 40.91, Section 40.93, Section 40.95 and Section 40.96; 40 CFR Part 40 (2017); and Section 11362.45(f), Health and Safety Code.